TL
Telix Pharmaceuticals Limited
TLPPF · OTC
$12.24 +11.17% (+$1.23)
1M +6.43%
Market Cap $5.82B
P/E Ratio -
Div. Yield -
ROE 1.74%
Bulios Fair Price
$16.72
36.6% upside
Trenutna cena
$12.24
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica TLPPF trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
8 /100
Expensive P/B 9.34x
EV/EBITDA 77.43x
P/S 4.67x
Growth
100 /100
Growing Book val. growth 98.17%
Rev. growth 98.18%
FCF growth N/A
Profitability
23 /100
Weak Op. margin 2.21%
Gross margin 53.11%
FCF margin 6.87%
Quality
13 /100
Poor ROA 0.62%
ROIC 2.56%
Asset turnover 0.70x
Debt
25 /100
High Int. coverage 0.86x
Debt/Equity 1.26x
Net debt/EBITDA 6.93x
Stability
26 /100
Unstable EPS volatility 463.92%
Beta 0.60x
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o TLPPF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Christian Behrenbruch
Employees
1,184
Headquarters
North Melbourne
Prihajajoči dogodki
19 FEB.
Earnings
Upcoming earnings report